Skip to main content
MicroPort Scientific Corporation logo

MicroPort Scientific Corporation — Investor Relations & Filings

Ticker · 853 ISIN · KYG608371046 LEI · 5299009MK4VZID944A20 HKEX Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 853

About MicroPort Scientific Corporation

http://www.microport.com.cn

MicroPort Scientific Corporation is a global medical technology group established in 1998, specializing in the R&D, manufacturing, and commercialization of high-quality, innovative medical device solutions. The company operates across multiple major therapeutic clusters, including cardiovascular and structural heart disease, orthopedics and sports medicine, cardiac rhythm management and electrophysiology, neurovascular systems, peripheral vascular systems, and medical robotics. With a commitment to making advanced healthcare universally accessible, MicroPort's extensive portfolio of over 600 solutions is deployed in more than 20,000 hospitals across the Asia Pacific, Europe, and the Americas. The corporation holds nearly 12,000 patents, underscoring its focus on technological innovation to extend and reshape patient lives globally.

Recent filings

Filing Released Lang Actions
2025 Environmental, Social and Governance Report
Regulatory Filings
2026-04-30 English
ANNUAL REPORT 2025
Regulatory Filings
2026-04-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 1% confidence The text is extremely short (242 characters) and simply states that an announcement has been published elsewhere, without containing substantive financial data or management discussion. This is a notice of publication rather than the report itself. Therefore, it fits the definition of a Report Publication Announcement (RPA).
2026-04-29 English
UNAUDITED FINANCIAL INFORMATION OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH (GROUP) CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2026
Earnings Release Classification · 1% confidence The document is an announcement on the Hong Kong Exchange detailing key unaudited financial information for the three months ended March 31, 2026, with revenue, profit, and balance sheet figures. It is clearly a first‐time quarterly results announcement (highlighting key metrics only) rather than a full comprehensive interim report or mere notice of report publication. This matches the definition of an Earnings Release (initial quarterly/periodic financial results). Q1 2026
2026-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is an HKEX Form FF301 Monthly Return under Chapter 19B of the Listing Rules, detailing movements in authorised share capital, issued shares, share options, convertibles and public float confirmation for the month ended. It is a periodical regulatory submission rather than an earnings release, management discussion, or dividend notice. It is not announcing a one-off capital transaction but is a standard regulatory filing. Therefore it falls under the general Regulatory Filings category (RNS).
2026-04-09 English
ESTABLISHMENT OF THE GLOBAL EXECUTIVE COMMITTEE AND CHANGES IN SENIOR MANAGEMENT POSITIONS
Board/Management Information Classification · 1% confidence The document is an announcement by the Board of MicroPort Scientific Corporation detailing the establishment of a new Global Executive Committee and changes in senior management roles. This fits the definition of a Board/Management Information filing, which covers announcements of changes in directors or senior management.
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.